本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Benitec Biopharma Limited

13.91
-0.0900-0.64%
盤後13.910.00000.00%18:44 EDT
成交量:3.87萬
成交額:53.94萬
市值:3.65億
市盈率:-9.49
高:14.30
開:14.06
低:13.68
收:14.00
52周最高:17.15
52周最低:8.06
股本:2,625.05萬
流通股本:1,288.63萬
量比:0.93
換手率:0.30%
股息:- -
股息率:- -
每股收益(TTM):-1.4658
每股收益(LYR):-5.5096
淨資產收益率:-48.57%
總資產收益率:-31.34%
市淨率:3.74
市盈率(LYR):-2.52

資料載入中...

2020/03/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/12

SEC問詢函

[Cover]Correspondence
2019/12/09

招股説明書

Registration statement for certain foreign private issuers
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/10/08

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]